These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9525550)

  • 1. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.
    Braun S; Boyko V; Behar S; Reicher-Reiss H; Laniado S; Kaplinsky E; Goldbourt U
    J Am Coll Cardiol; 1998 Mar; 31(4):804-8. PubMed ID: 9525550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cancer in postmyocardial infarction patients treated with short-acting nifedipine and diltiazem. Secondary Prevention Group.
    Kanamasa K; Kimura A; Miyataka M; Takenaka T; Ishikawa K
    Cancer; 1999 Mar; 85(6):1369-74. PubMed ID: 10189144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study.
    Beiderbeck-Noll AB; Sturkenboom MC; van der Linden PD; Herings RM; Hofman A; Coebergh JW; Leufkens HG; Stricker BH
    Eur J Cancer; 2003 Jan; 39(1):98-105. PubMed ID: 12504665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of angina pectoris with calcium antagonists: long-term follow-up.
    Behar S
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():119-24. PubMed ID: 9642485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior calcium channel blockade and short-term survival following acute myocardial infarction.
    Parsons RW; Hung J; Hanemaaijer I; Jbroadhurst R; Jamrozik K; Hobbs MS
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):487-92. PubMed ID: 11916357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients.
    Braun S; Boyko V; Behar S; Reicher-Reiss H; Shotan A; Schlesinger Z; Rosenfeld T; Palant A; Friedensohn A; Laniado S; Goldbourt U
    J Am Coll Cardiol; 1996 Jul; 28(1):7-11. PubMed ID: 8752787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer.
    Meier CR; Derby LE; Jick SS; Jick H
    Arch Intern Med; 2000 Feb; 160(3):349-53. PubMed ID: 10668837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly.
    Bettiol A; Lucenteforte E; Vannacci A; Lombardi N; Onder G; Agabiti N; Vitale C; Trifirò G; Corrao G; Roberto G; Mugelli A; Chinellato A;
    Clin Drug Investig; 2017 Dec; 37(12):1165-1174. PubMed ID: 28975522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies concerning calcium antagonists.
    Lichtlen PR
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):409-12. PubMed ID: 8924053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of diltiazem and verapamil on mortality and cardiac events in non-Q-wave acute myocardial infarction without pulmonary congestion: post hoc subset analysis of the multicenter diltiazem postinfarction trial and the second danish verapamil infarction trial studies.
    Gibson RS; Hansen JF; Messerli F; Schechtman KB; Boden WE
    Am J Cardiol; 2000 Aug; 86(3):275-9. PubMed ID: 10922432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine and cancer mortality: ten-year follow-up of 2607 patients after acute myocardial infarction.
    Jonas M; Goldbourt U; Boyko V; Mandelzweig L; Behar S; Reicher-Reiss H
    Cardiovasc Drugs Ther; 1998 May; 12(2):177-81. PubMed ID: 9652876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
    Bangalore S; Parkar S; Messerli FH
    Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    Opie LH
    Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Stahl M; Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Webster J
    J Hum Hypertens; 2000 May; 14(5):299-304. PubMed ID: 10822315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of clopidogrel and calcium channel blockers and risk of major adverse cardiovascular events.
    Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA
    Eur J Clin Invest; 2012 Mar; 42(3):266-74. PubMed ID: 21834799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of calcium channel blocker in the secondary prevention of myocardial infarction--retrospective analysis of the 10-year prognosis or coronary thrombolysis-treated patients.
    Tani S; Watanabe I; Nagao K; Kikushima K; Watanabe K; Anazawa T; Kawamata H; Tachibana E; Furuya S; Sasanuma T; Kushiro T; Kanmatsuse K
    Circ J; 2004 Sep; 68(9):853-9. PubMed ID: 15329508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
    J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.